Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Femasys Q2 EPS $(0.22) Up From $(0.52) YoY

Femasys Q2 EPS $(0.22) Up From $(0.52) YoY

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.22) per share. This is a 57.69 percent increase over losses of $(0.52) per share from the same period last year.

byBenzinga Newsdesk

August 10, 2022

1 minute read

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.22) per share. This is a 57.69 percent increase over losses of $(0.52) per share from the same period last year.

Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $55

By Benzinga Newsdesk

August 10, 9:25 AM

Morgan Stanley analyst Vikram Purohit maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $54 to $55.

AXSM

Earnings

Recap: Velo3D Q4 Earnings

By Benzinga Insights

March 26, 4:15 PM

Velo3D (NYSE:VLD) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:05 PM. Here’s what investors…

VLD

News

ObsEva To Increase Issued Share Capital By Creating Additional Treasury Shares

By Benzinga Newsdesk

December 9, 8:01 AM

ObsEva SA (NASDAQ:OBSV, SIX: OBSN)))), a biopharmaceutical company developing and commercializing novel therapies for women's health, announced today that its board of directors approved on December 8, 2022 an

OBSV